Willis Investment Counsel Cyto Dyn Inc. Transaction History

Willis Investment Counsel

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	BUY	$0.37 - $1.02 $4,823 - $13,297	13,037 New	13,037 $5,000
Q3 2021 Nov 17, 2021	SELL	$1.27 - $2.46 $110,790 - $214,603	-87,237 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$1.67 - $3.98 $145,685 - $347,203	87,237 New	87,237 $148,000
Q1 2021 May 17, 2021	SELL	$2.12 - $7.15 $36,040 - $121,550	-17,000 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$2.02 - $6.0 $34,340 - $102,000	17,000 New	17,000 $92,000
Q3 2018 Nov 15, 2018	SELL	$0.43 - $0.7 $19,554 - $31,832	-45,475 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$0.44 - $0.59 $20,009 - $26,830	45,475 New	45,475 $21,000

406K

Ticker CYDY
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 813,040,000
Market Cap $89.4M
Description
CytoDyn Inc. operates as a clinical-stage biotechnology company. The company focuses on developing treatments for multiple therapeutic indications based on leronlimab, a novel humanized monoclonal antibody targeting the CCR5 receptor in the areas of human immunodeficiency virus (HIV), non-alcoholic steatohepatitis (NASH), oncology, and such as c...

Get notified when there are updates to the investment portfolio of Willis Investment Counsel, based on Form 13F filings with the SEC.

Stay updated on Willis Investment Counsel with notifications on news.